View More Recent Stories
-
Relay Therapeutics (RLAY) Announces $200M Proposed Public Offering of Common Stock
-
TD Cowen Out Positive on Relay Therapeutics (RLAY), Shares Up ~53%, 'we are constructive on Ph3 success based on today's data'
-
Relay Therapeutics (RLAY) Shares Gain ~51%, PT Raised to $17 at Barclays
-
Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
-
Relay Therapeutics (RLAY) PT Lowered to $20 at BofA Securities
-
Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 4c
-
Relay Therapeutics (RLAY) PT Lowered to $18 at H.C. Wainwright
